Ailish Mc Cartan
About Ailish Mc Cartan
Ailish Mc Cartan is the Manager and Senior Scientist in Process Analytics at Bristol-Myers Squibb in Dublin, with extensive experience in bioanalytical sciences and process optimization.
Title and Current Role
Ailish Mc Cartan is currently serving as Manager, Senior Scientist Process Analytics at Bristol-Myers Squibb in Dublin, Leinster, Ireland. In her current role, she is actively involved in process analytics, leveraging her extensive experience and skills in bioanalytical methodologies and process optimization.
Previous Work Experience
Ailish Mc Cartan has accumulated substantial experience throughout her career, having worked for prominent pharmaceutical companies. Prior to her current role, she worked at Alexion Pharmaceuticals, Inc. as a Senior QC Analyst (2016-2017) and at Amgen as a QC Associate in Bioanalytical Sciences (2011-2015). Her initial roles in the industry included a position at Pfizer as a QC Biologics Analyst (2007-2011) and at Trinity Biotech as a Team Leader Cell Culture/Bioprocessing Analyst (2004-2007).
Education and Credentials
Ailish Mc Cartan pursued her higher education at Dublin Institute of Technology, where she earned a Bachelor's degree in Biochemistry and Molecular Biology between 2002 and 2004. Prior to that, she studied at Dundalk Institute of Technology and achieved a National Diploma in Food Science and Technology, completing her studies there from 1999 to 2002.
Project Leadership in MS&T
Ailish Mc Cartan has been at the forefront of numerous significant projects in her field. Notably, she led projects for molecule introductions to Manufacturing Science and Technology (MS&T) teams. Her leadership has been instrumental in advancing the capabilities and efficiency of these teams.
Technical Expertise and Responsibilities
Ailish Mc Cartan possesses extensive expertise in upstream and downstream process optimization. She has managed core excellence teams responsible for bioanalytical methodologies for several years. Her technical skillset includes troubleshooting bioassay/immunoassay, capillary electrophoresis, and gel technologies. Additionally, she has played a key role in BLA filings and site registration inspections for both clinical and commercial molecules.